NCT00929396 A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis (TB) Subunit Vaccine in Purified Protein Derivative (PPD) Positive Volunteers Status COMPLETED Phase PHASE1
NCT00925249 Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT-G) In Patients With Rheumatoid Arthritis Being Considered for Anti-TNF-Alpha Therapy Status UNKNOWN Phase N/A
NCT00922363 Trial on the Safety of a New Liposomal Adjuvant System, CAF01, When Given With the Tuberculosis Subunit Vaccine Ag85B-ESAT-6 as Two Injections With Two Months Interval to Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT00918086 Impact of Vitamin D Supplementation on Host Immunity to Mycobacterium Tuberculosis and Response to Treatment Status COMPLETED Phase PHASE2
NCT00915330 Rapid On-site Cytopathologic Evaluation in the Diagnosis of Hilar/Mediastinal Adenopathy Status COMPLETED Phase NA
NCT00910871 To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB. Status COMPLETED Phase PHASE2
NCT00904956 Study of Latent Tuberculosis Infection (LTBI) by High Resolution Scanner Status UNKNOWN Phase N/A
NCT00889759 The Role of High Resolution-Computed Tomography (CT) in Tuberculosis (TB) Outbreak Investigation Status COMPLETED Phase N/A
NCT00871949 Safety, Tolerability And Pharmacokinetics Study Of Single Doses Of PNU-100480 In Healthy Adults Status COMPLETED Phase PHASE1
NCT00865826 Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals Status COMPLETED Phase N/A
NCT00851630 Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial (THIRST) Status COMPLETED Phase PHASE4
NCT00850915 Feasibility and Effectiveness of Community Based Isoniazid Preventive Therapy in Kenya Status COMPLETED Phase PHASE4
NCT00828529 TMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy Volunteer Status COMPLETED Phase PHASE1
NCT00822315 Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis Status COMPLETED Phase PHASE2
NCT00816426 Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis Status COMPLETED Phase PHASE1
NCT00811343 Impact of New Immunological Diagnosis Tests of Latent Tuberculosis Before Anti TNF Therapy Status COMPLETED Phase NA